Rate of bactericidal activity for Streptococcus faecalis of a new quinolone, CI-934, compared with that of amoxicillin. 1986

E Yourassowsky, and M P Van der Linden, and M J Lismont, and F Crokaert, and Y Glupczynski

The rate of bactericidal activity of a new quinolone, CI-934, was compared with that of amoxicillin for 20 strains of Streptococcus faecalis. At 10 and 100 micrograms/ml, the bactericidal activity of CI-934 was more rapid at 6 h than that of amoxicillin. A paradoxical effect (a killing rate higher at 1 microgram/ml than at 100 micrograms/ml at 6 h) was observed for 19 of the 20 strains with amoxicillin and for 1 of the 20 strains with CI-934. It remains to be demonstrated whether in vivo studies will confirm the results obtained in vitro.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011804 Quinolines
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000658 Amoxicillin A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration. Hydroxyampicillin,Actimoxi,Amoxicillin Anhydrous,Amoxicillin Monopotassium Salt,Amoxicillin Monosodium Salt,Amoxicillin Sodium,Amoxicillin Trihydrate,Amoxicillin, (R*)-Isomer,Amoxicilline,Amoxil,Amoxycillin,BRL-2333,Clamoxyl,Clamoxyl G.A.,Clamoxyl Parenteral,Penamox,Polymox,Trimox,Wymox,BRL 2333,BRL2333
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013293 Enterococcus faecalis A species of gram-positive, coccoid bacteria commonly isolated from clinical specimens and the human intestinal tract. Most strains are nonhemolytic. Streptococcus Group D,Streptococcus faecalis
D024841 Fluoroquinolones A group of QUINOLONES with at least one fluorine atom and a piperazinyl group. Fluoroquinolone

Related Publications

E Yourassowsky, and M P Van der Linden, and M J Lismont, and F Crokaert, and Y Glupczynski
May 1986, Antimicrobial agents and chemotherapy,
E Yourassowsky, and M P Van der Linden, and M J Lismont, and F Crokaert, and Y Glupczynski
June 1986, European journal of clinical microbiology,
E Yourassowsky, and M P Van der Linden, and M J Lismont, and F Crokaert, and Y Glupczynski
December 1986, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
E Yourassowsky, and M P Van der Linden, and M J Lismont, and F Crokaert, and Y Glupczynski
January 1990, The Journal of antimicrobial chemotherapy,
E Yourassowsky, and M P Van der Linden, and M J Lismont, and F Crokaert, and Y Glupczynski
November 1986, Diagnostic microbiology and infectious disease,
E Yourassowsky, and M P Van der Linden, and M J Lismont, and F Crokaert, and Y Glupczynski
August 1986, The Journal of antimicrobial chemotherapy,
E Yourassowsky, and M P Van der Linden, and M J Lismont, and F Crokaert, and Y Glupczynski
April 1987, Diagnostic microbiology and infectious disease,
E Yourassowsky, and M P Van der Linden, and M J Lismont, and F Crokaert, and Y Glupczynski
December 1985, Antimicrobial agents and chemotherapy,
E Yourassowsky, and M P Van der Linden, and M J Lismont, and F Crokaert, and Y Glupczynski
December 1986, European journal of clinical microbiology,
E Yourassowsky, and M P Van der Linden, and M J Lismont, and F Crokaert, and Y Glupczynski
December 1986, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!